About
About this Poster:
SAR438544 is a novel synthetic agonist of the glucagon receptor in a stable formulation for subcutaneous (SC) injection to treat hypoglycemia. A first-in-human, randomized, double-blind, glucagon and placebo-controlled, single ascending dose study to evaluate safety, tolerability, PK and PD of SAR438544 was conducted in healthy volunteers.
![The novel glucagon receptor agonist SAR438544, first in human safety, pharmacokinetic and pharmacodynamic data from a study in healthy volunteers thumbnail](https://prosciento.com/wp-content/uploads/2022/01/poster-24.png)